191 related articles for article (PubMed ID: 36303408)
1. LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report.
Cardaci TD; Machek SB; Wilburn DT; Heileson JL; Harris DR; Cintineo HP; Willoughby DS
Exp Physiol; 2022 Dec; 107(12):1467-1476. PubMed ID: 36303408
[TBL] [Abstract][Full Text] [Related]
2. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.
Basaria S; Collins L; Dillon EL; Orwoll K; Storer TW; Miciek R; Ulloor J; Zhang A; Eder R; Zientek H; Gordon G; Kazmi S; Sheffield-Moore M; Bhasin S
J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):87-95. PubMed ID: 22459616
[TBL] [Abstract][Full Text] [Related]
3. Delta-4-androstene-3,17-dione binds androgen receptor, promotes myogenesis in vitro, and increases serum testosterone levels, fat-free mass, and muscle strength in hypogonadal men.
Jasuja R; Ramaraj P; Mac RP; Singh AB; Storer TW; Artaza J; Miller A; Singh R; Taylor WE; Lee ML; Davidson T; Sinha-Hikim I; Gonzalez-Cadavid N; Bhasin S
J Clin Endocrinol Metab; 2005 Feb; 90(2):855-63. PubMed ID: 15522925
[TBL] [Abstract][Full Text] [Related]
4. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
Young NR; Baker HW; Liu G; Seeman E
J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
[TBL] [Abstract][Full Text] [Related]
5. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice.
Chisamore MJ; Gentile MA; Dillon GM; Baran M; Gambone C; Riley S; Schmidt A; Flores O; Wilkinson H; Alves SE
J Steroid Biochem Mol Biol; 2016 Oct; 163():88-97. PubMed ID: 27106747
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
Isidori AM; Giannetta E; Greco EA; Gianfrilli D; Bonifacio V; Isidori A; Lenzi A; Fabbri A
Clin Endocrinol (Oxf); 2005 Sep; 63(3):280-93. PubMed ID: 16117815
[TBL] [Abstract][Full Text] [Related]
7. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.
van den Beld AW; de Jong FH; Grobbee DE; Pols HA; Lamberts SW
J Clin Endocrinol Metab; 2000 Sep; 85(9):3276-82. PubMed ID: 10999822
[TBL] [Abstract][Full Text] [Related]
8. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
Nass R; Pezzoli SS; Oliveri MC; Patrie JT; Harrell FE; Clasey JL; Heymsfield SB; Bach MA; Vance ML; Thorner MO
Ann Intern Med; 2008 Nov; 149(9):601-11. PubMed ID: 18981485
[TBL] [Abstract][Full Text] [Related]
9. Strength training as a supplemental therapy for androgen deficiency of the aging male (ADAM): study protocol for a three-arm clinical trial.
Kralik M; Cvecka J; Buzgo G; Putala M; Ukropcova B; Ukropec J; Killinger Z; Payer J; Kollarik B; Bujdak P; Raastad T; Sedliak M
BMJ Open; 2019 Sep; 9(9):e025991. PubMed ID: 31492775
[TBL] [Abstract][Full Text] [Related]
10. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
Mueller A; Haeberle L; Zollver H; Claassen T; Kronawitter D; Oppelt PG; Cupisti S; Beckmann MW; Dittrich R
J Sex Med; 2010 Sep; 7(9):3190-8. PubMed ID: 20584125
[TBL] [Abstract][Full Text] [Related]
11. A selective androgen receptor modulator SARM-2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys.
Morimoto M; Yamaoka M; Hara T
Pharmacol Res Perspect; 2020 Feb; 8(1):e00563. PubMed ID: 32030892
[TBL] [Abstract][Full Text] [Related]
12. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
[TBL] [Abstract][Full Text] [Related]
13. Effects of androgenic-anabolic steroids in athletes.
Hartgens F; Kuipers H
Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.
Attardi BJ; Marck BT; Matsumoto AM; Koduri S; Hild SA
J Androl; 2011; 32(2):183-92. PubMed ID: 20798389
[TBL] [Abstract][Full Text] [Related]
15. Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677.
Svensson J; Carlsson B; Carlsson LM; Jansson JO; Bengtsson BA
Clin Endocrinol (Oxf); 1999 Apr; 50(4):451-6. PubMed ID: 10468903
[TBL] [Abstract][Full Text] [Related]
16. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
[TBL] [Abstract][Full Text] [Related]
17. Development of models to predict anabolic response to testosterone administration in healthy young men.
Woodhouse LJ; Reisz-Porszasz S; Javanbakht M; Storer TW; Lee M; Zerounian H; Bhasin S
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1009-17. PubMed ID: 12517741
[TBL] [Abstract][Full Text] [Related]
18. Aging-related decline of gonadal function in healthy men: correlation with body composition and lipoproteins.
Denti L; Pasolini G; Sanfelici L; Benedetti R; Cecchetti A; Ceda GP; Ablondi F; Valenti G
J Am Geriatr Soc; 2000 Jan; 48(1):51-8. PubMed ID: 10642021
[TBL] [Abstract][Full Text] [Related]
19. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
20. Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease.
Bhasin S; Krishnan V; Storer TW; Steiner M; Dobs AS
J Gerontol A Biol Sci Med Sci; 2023 Jun; 78(Suppl 1):25-31. PubMed ID: 37325955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
